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1. Abstract 
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 
million people worldwide and is the 6th leading cause of death in the United States.  AD is 
characterized by neurofibrillary tangles and amyloid plaques in the brain.  The plaques are 
formed when amyloid beta (Aβ) peptides aggregate at their hydrophobic residues.  Elevated 
concentrations of essential metals, copper, iron, and zinc, have been detected in the plaques and 
research indicates that the presence of metals speed up the formation of the plaques.   
Previous binding studies have determined that metal binding occurs within the first 16 
amino acids of the Aβ peptide, which can be either 40 or 42 amino acids long.  The rat Aβ 
peptide differs by only three amino acid point substitutions and are immune to aggregation.  
Based on previous thermodynamic binding studies, the exposure of the peptides’ hydrophobic 
residues when bound to copper (II) are hypothesized to be more exposed in the human peptide 
than the rat.  To test this hypothesis, rat and human Aβ28 peptides are probed with hydrophobic 
fluorophore 1,8-ANS.  Increased fluorescence is expected of human Aβ28 if the hydrophobic 
residues of the peptide-copper complexes are indeed more exposed.  
 
2. Alzheimer’s Disease 
The well-known devastation of Alzheimer’s Disease (AD) paired with the mystery 
surrounding the disease has made it a popular research topic across many scientific fields.  AD is 
the sixth leading cause of death in the United States with approximately 36 million cases 
worldwide [1-3].  It is a progressive, neurodegenerative disease that accounts for the majority of 
dementia cases [1].  AD causes loss of neurons in the cerebral cortex and the brain to atrophy, 
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which leads to loss of cognitive function, memory, behavioral and physical ability, and 
ultimately loss of life [2-4]. 
AD is characterized by amyloid plaques, the primary constituent of which is the amyloid-
β (Aβ) peptide [2-8], and neurofibrillary tangles, comprised from hyper phosphorylated tau 
protein [2-4, 6,].  The physical effect of the plaques and tangles are visible in Figure 1 [1].  The 
significance of the rat Aβ peptides is that, though they are produced similarly to the human 
peptide and differ by only three point substitutions, they do not aggregate to form amyloid 
plaques [8]. 
 
 
 
 
 
 
 
 
 
2.1 Amyloid-β 
  The Aβ peptide is derived from the cleavage of the amyloid precursor protein (APP) 
from the outer cell membrane or mitochondrial membrane [3, 4, 8].  APP is cleaved by either α-, 
β-, or γ-secretase [3, 6, 9], the latter of which results in Aβ peptides between 39 and 43 amino 
acids in length with the most common being 40 and 42 [2-9].  The sequence of human Aβ42 with 
Figure 1. Figure of healthy neurons in the brain (inset) and neurons affected by 
Alzheimer’s disease plaques and tangles [1]. 
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the hydrophobic residues highlighted in green and the metal binding histidine residues 
highlighted in blue is as follows in Scheme 1. 
 
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA 
Scheme 1. Sequence of Human Aβ	  peptide 
 
The rat Aβ42 with highlighted hydrophobic and metal-binding residues with its three point 
substitutions in red is as follows in Scheme 2. 
 
DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA 
Scheme 2. Sequence of Human Aβ	  peptide 
 
The 42 amino acid long peptide is more prone to aggregation into oligomers then further 
into the amyloid plaques [3-5, 9].  The amyloid cascade hypothesis suggests that this aggregation 
occurs at the hydrophobic residues (Figure 2) and that these aggregates or plaques cause neural 
dysfunction.  This dysfunction leads to incorrect processing of the tau protein, which leads to the 
formation of the neurofibrillary tangles [3, 9]. 
 
Figure 2. Figure representing the formation of Aβ monomers, oligomers and fibrils.  
[3-5, 9]. 
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Elevated concentrations of essential metals, copper, zinc, and iron, have been detected in 
the plaques and are known to enhance aggregation [3-5, 7].  The three histidine residues within 
the Aβ peptide play a role in the peptide’s ability to bind metals within the first 16 amino acids 
[3, 4].  The metal ion hypothesis of AD pathogenesis suggests that the imbalance in metal 
homeostasis is the underlying precursor to amyloid plaque formation [3]. 
A third hypothesis for the pathogenesis of AD competing with the amyloid cascade and 
metal ion hypotheses is the oxidative stress hypothesis [3].  It states that oxidative stress from 
reactive oxygen species causes gene defects, leading to neurodegeneration, and ultimately plaque 
aggregation and subsequent neurological disorders [3]. 
 
2.2 Previous thermodynamic studies 
 As previously noted, copper (Cu2+) can bind to Aβ within its first 16 amino acid residues.  
Thermodynamic studies into Cu2+ binding to Aβ involving the determination of binding 
constants and changes in enthalpy (ΔH), entropy (ΔS), and overall Gibb’s free energy (ΔG) have 
been conducted in the Spuches lab group using isothermal titration calorimetry [4, 10].  Though 
the ΔH and TΔS of Cu2+ binding to human and rat Aβ28 peptides varied slightly (Figure 3), the 
ΔG for each, which indicates spontaneity or favorability of a reaction, were identical: -6.5 ± 0.2 
and -6.3 ± 0.1 kcal/mol at 37°C respectively [4, 10].   
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Figure 3. Thermodynamic parameters for Cu2+ binding to human and rat 
Aβ28 [10].  All samples contained 20 mM ACES Buffer (pH = 7.4), 0.1 M 
NaCl and run at 37 °C. 
 
For further elucidation of how the metal and peptide are binding, the heat capacity of the 
reactions were determined [10].  Heat capacity (Cp) is a measure of the heat required to raise the 
temperature of a system by one degree.  Typically, a negative Cp value for protein binding is 
indicative of more buried hydrophobic surfaces [10, 12]. 
 
 
 
Figure 4.  Change in enthalpy as a function of temperature for human and rat Aβ 
with 2.1 mM Cu2+ [10].  Samples contained 20 mM ACES Buffer (pH = 7.4), 0.1 
M NaCl. and reactions were conducted at 37 °C. 
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The Cp of human and rat Aβ28 was determined from the linear slope of ΔH versus 
temperature (T) shown in Figure 4 [10].  Their values were determined to be 25 ± 3 and -71 ± 1 
cal/mol∙°C for human and rat peptide respectively.  Based on the much more negative heat 
capacity of rat Aβ28 binding Cu2+, the hydrophobic residues of the rat peptide are hypothesized 
to be more buried within the metal-peptide complex than the human as depicted in Figure 5 [10].  
To test this hypothesis, the human and rat complexes were probed with a hydrophobic 
fluorophore. 
 
 
 
3. Fluorometry 
Fluorescence along with phosphorescence make up the two categories of luminescence, 
which encompasses any light that is emitted by a compound from an electronically excited state 
[13].  In fluorescence, paired and opposite-spin electrons are excited to a single state electronic 
level (S1) before decaying back down to the ground state (S0).  In phosphorescence, same-spin 
electrons are excited to a triplet state (T1) [13].  The Jablonski diagram in Figure 6 displays the 
excitation, decay, and emission of fluorescence and phosphorescence compared to absorption 
[13].  Not all molecules fluoresce, because once excited, a molecule will return to the ground 
state in the quickest manner possible.  The lifetime of fluorescence is about 10-8 seconds whereas 
Figure 5.  Proposed structures of the metal-peptide complex of A) human Aβ28 
and B) rat Aβ28 [10]. 
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the lifetime of absorbance is shorter, 10-15 seconds, and thus preferred [13].  Rigid, aromatic 
compounds are often fluorescent because there is less flexibility, meaning less possible 
vibrational relaxation as in absorption. 
 
 
	  
 
A distinct characteristic of fluorescence is that it emits light energy at longer wavelengths 
than the wavelength at which it was excited.  Typical absorption spectra of two fluorescent 
molecules are displayed in Figure 7 [13].  This lower-energy emission is referred to as the 
Stokes shift [13].  The Stokes shift is mostly a result of rapid energy loss to the lowest 
vibrational level within the excited electronic level (S1) [13].  Fluorescent molecules also tend to 
decay to higher vibrational levels within the ground state (S0).   
Other causes of the Stokes shift may include solvent effects, reactions that take place at 
the excited state, and energy transfer [13].  Another effect of fluorescent molecules’ rapid 
relaxation at their excited states is that the emission spectrum of a particular fluorophore is 
Figure 6.  Simple Jablonski diagram of absorption, fluorescence, and 
phosphorescence. [13]. 
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independent of excitation wavelength; if excited to a higher electronic or vibrational level, the 
excess energy is quickly dissipated [13]. 
 
 
 
 
Though the emission spectrum of a fluorophore is independent of excitation, changes in  
λmax and intensities may still arise from changes in environment.  A shift of the λmax to the left to 
a shorter wavelength is known as a blue shift [13].  A shift of the λmax to the right of a 
fluorescence spectrum to a longer wavelength is referred to as a red shift [13].  A red shift may 
occur in polar solvents because the excited electrons may be able to resonate before relaxing, 
causing it to emit light at a lower and more stable energy.  For example, the indole group of 
Figure 7.  Absorption and emission of perylene (top) and quinine (bottom) [13]. 
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tryptophan displays a blue shift when buried within a protein and red shift when the protein is 
unfolded [13]. 
The decrease in fluorescence intensity of a fluorophore is called quenching [13].  
Quenching is the process in which a fluorophore in an excited state returns to the ground state 
without emitting light.  This process may occur via dynamic/collisional or static quenching.  
Dynamic or collisional quenching occurs from diffusive encounters with another molecule in 
solution, which would act as a quencher.  Static quenching is a result of the formation of a non-
fluorescent compound from a fluorophore and a quencher.  A fluorophore that is free in solution 
is generally more sensitive to quenching than one that is buried within a macromolecule [13]. 
 
4. Project Objectives 
The thermodynamic findings from the previous work conducted in the Spuches lab 
suggested that the rat Aβ28 might have a more compact metal-peptide complex with Cu2+ as 
observed in Figure 3 [10].  A more compact structure would provide some explanation for why 
the rat Aβ peptide does not aggregate at its hydrophobic residues like the human Aβ peptide.  
The aggregation of the human peptide can lead to the formation of the amyloid plaques that the 
rat peptides do not form.  As a means of supporting this hypothesis, a hydrophobic fluorophore 
1,8-ANS, was used to probe human and rat Aβ28 peptides that were free in solution and 
complexed to Cu2+.  If the rat complex is more compact than the human, the fluorescent probe 
should show a more decreased intensity in its presence. 
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5. Materials 
All solutions in this experiment were prepared with a buffer that consisted of 20 mM N-
(2-Acetonido)-2-aminoethansulfonic acid (ACES, Sigma-Aldrich, St. Louis, MO) and 100 mM 
sodium chloride (NaCl) in 18 MΩ deionized water.  Sodium hydroxide was added to reach a pH 
of 7.4.  A 5mM Cu2+ stock was also prepared with 20 mM ACES and 100 mM NaCl (pH 7.4).  
The fluorophore used as a fluorescent hydrophobic probe in this experiment was 1-
Anilinonaphthalene-8-sulfonic acid, (1,8-ANS), which can be seen in Figure 8, was ordered 
from Life Technologies (Carlsbad, CA).  The fluorophore solution was prepared by dissolving it 
in 0.5000 mL of the buffer and 0.5000 mL of dimethylsulfoxide (DMSO).  Its concentration was 
determined from its absorbance at 350 nm (ε = 5000 M-1cm-1) using a Thermo Scientific 
NanoDrop 200C spectrophotometer (Waltham, MA).  
 
 
 
5.1. Peptide purification 
Crude Aβ peptides were ordered from the Keck Biotechnology Resource Laboratory 
(Yale University, New Haven, CT).  This length of the peptide was chosen to be 28 amino acids 
because it contains the residues involved in metal binding and one of the prominent hydrophobic 
Figure 8.  Structure of 1,8-ANS from LifeTechnologies.com 
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patches.  Full length (40 or 42 amino acids) was not used because of the possibility for 
aggregation within the time the tests were conducted.  The truncated forms of the peptides are 
depicted in Scheme 3. 
 
Human Aβ:  DAEFRHDSGYEVHHQKLVFFAEDVGSNK 
Rat Aβ:  DAEFGHDSGFEVRHQKLVFFAEDVGSNK 
Scheme 3. Sequence of human and rat Aβ	  peptides 1-28. 
 
The peptides were purified with BioLogic DuoFlow HPLC with UV-Vis detector (Bio-
Rad, Hercules, CA) utilizing a Vydac Protein and Peptide C18 column (Grace Davison Discover 
Sciences, Columbia, MD).  A gradient flow was utilized with 80% acetonitrile, 19.95% 18 MΩ 
deionized water, and 0.05% trifluoroacetic acid as solvent A and 99.95% 18 MΩ deionized water 
and 0.05% TFA as solvent B.  Approximately 10 mg of the peptide was dissolved in DMSO and 
diluted with water.  Sonication was necessary to completely dissolve the peptides.  The solutions 
were filtered with a Whatman 0.45 µm filter-tip syringe (GE Healthcare, Pittsburgh, PA).  The 
method used for the purification of the human and rat peptides can be seen in Table 1. 
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After collection, the peptide solution was flash frozen and lyophilized with a Labconco 
FreeZone 2.5 (Kansas City, MO) to sublimate the solvent from the peptide.  The remaining 
peptide was dissolved in ACES buffer to determine its concentration from its absorbance.  The 
presence of tyrosine in the human peptide (ε = 1410 cm-1M-1 at 280 nm) made concentration 
determination possible.  The tyrosine in the human peptide is substituted for phenylalanine in the 
rat (ε = 195 cm-1M-1 at 257.5 nm).  Because there is a total of 4 phenylalanine residues present in 
rat Aβ, the concentration of the amino acid was divided by 4 to calculate the concentration of the 
entire peptide. 
 
 
 
Table 1.  Method utilized in the purification of rat and human peptides.  Solvent A is 80% 
acetonitrile, 19.95% 18 MΩ deionized water, and 0.05% TFA.  Solvent B is 99.95% 18 MΩ 
deionized water and 0.05% TFA. 
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5.2. Sample Preparation 
 All samples were prepared in the 20 mM ACES Buffer (pH = 7.4), 0.1 M NaCl.  Each 
sample contained equal concentrations of peptide and fluorophore and the copper solution was 
1.5 times that of the peptide.  Two controls were prepared to compare against the peptides of 
interest.  The first was the spectrum of 1,8-ANS in buffer and the second took into account the 
quenching power of free Cu2+.  The spectra of each peptide alone and in the Cu2+ complex were 
also gathered.  The contents and concentrations of each sample are displayed in Table 2.  
Samples 4 and 6 consisting of the human and rat complexes were incubated for 2.5 hours at a 
temperature of 37°C. 
Table 2.  Contents of all samples run in fluorometer. 
Samples contained 20 mM ACES Buffer (pH = 7.4), 
0.1 M NaCl and incubated at 37 °C. 
 
 
The spectra were gathered with a Photon Technology International (PTI) QuantaMaster 
Fluorometer System (Monmouth Junction, NJ).  Excitation was set at 375 nm and each sample’s 
emission was scanned from 400 to 700 nm three times per sample in increments of 1 nm every 
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0.25 seconds.  The peaks were integrated from 400 to 680 nm with the PTI Felix32 software to 
obtain the peak areas.  To obtain peak maximums (λmax), the curves were differentiated by the 
spectral processing program to obtain linear equations.  The x-intercept of the line was recorded 
as the λmax of each sample. 
 
6. Results and Discussion 
The spectra of all six samples are displayed in Figure 9.  A summary of the intensity and 
λmax of each sample is presented in Table 3.  The Cu2+ buffer solution did display some 
quenching power noted by the 4.4% decrease in intensity.  However, this effect was minimal and 
not considered to cause much interference based on the much larger intensities displayed by the 
introduction of peptide. Furthermore, the presence of “free” Cu2+ is even more reduced in the 
metal-peptide complex solutions due to binding to the peptide. 
The spectra of the human Aβ28 peptide with probe and in complex with Cu2+ (Figure 
9A) display a blue shift from the controls.  The blue shift of the free peptide from the controls 
indicates that the probe was in a more hydrophobic environment upon excitation.  This blue shift 
is observed in the free and complexed rat Aβ28 peptide as well (Figure 9B), however two 
important differences are noted.   
First, the intensity of the fluorophore observed in the rat peptide is greater than the 
intensity observed in the human peptide.  This would suggest that the rat peptide has more 
exposed hydrophobic residues than the human peptide and indeed the rat has two additional 
hydrophobic residues than the human, with two of these near the Cu2+ binding site.  The second 
difference is that the blue shift is much larger for the rat than the human again indicating a more 
hydrophobic environment.  Taken together, we believe that the rat peptide has more structure in 
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solution than the human peptide and that these residues have formed a hydrophobic patch or 
pocket thus creating a more hydrophobic environment. 
Upon complexation with Cu2+, the fluorophore displayed a decrease in intensity with 
both human and rat peptides.  This decrease is likely the result of dynamic quenching as a 
consequence of more probe in solution rather than in the presence of hydrophobic amino acid 
residues.  This quenching reveals that the metal-peptide complex of human and rat Aβ28 has a 
more compact structure than unbound peptide.  A larger decrease in intensity is exhibited by the 
fluorophore from free rat Aβ28 to the metal-peptide complex (50.5%) than from the free human 
to its complex (21.4%).  From this trend, the conformational change in the rat peptide is believed 
to be more pronounced than the human.  
 
 
Figure 9.  Spectra of the controls, probe (black) and probe plus Cu2+ (grey) are displayed in both 
A and B.  Human peptide with probe (blue) and with Cu2+plus probe (green) are displayed in A.  
Rat peptide with probe (purple) and with Cu2+ plus probe (red) are displayed in B.  All samples 
contained 20 mM ACES Buffer (pH = 7.4), 0.1 M NaCl. 
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Table 3.  Summary of fluorometry data. 
 
 
7. Conclusions 
The fluorometric spectra of human and rat Aβ28 peptides free in solution and complexed 
with Cu2+ were collected in this experiment.  The results support the hypothesis that, upon 
binding Cu2+, the rat peptide takes on a more compact structure as displayed in Figures 5 and 10.  
The larger decrease in intensity from free peptide to complex was the greatest determining factor 
of this conclusion in correlation to intensity trends stated by Lakowicz [13].  The slight red shift 
from free peptide to complexed also corroborates this conclusion.   
 The more compact structure taken on by the rat Aβ28 peptide makes its hydrophobic 
residues less exposed than the human.  From previous studies, it is known that aggregation 
occurs at the hydrophobic residues of the human Aβ peptide to form amyloid plaques, which are 
not detected in rats as displayed in Figure 10 [3, 5, 8, 9].  The results of this experiment suggest 
that the lack of amyloid plaques in rats is due to the decrease in exposure of their Aβ peptides’ 
hydrophobic residues upon Cu2+ complexation, which in turn prohibits oligomer and fibril 
formation at the hydrophobic residues. 
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Figure 10.  Pictorial representation of human Aβ complex undergoing fibril 
formation as a result of exposed hydrophobic residues while the more compact rat 
Aβ complex does not due to buried residues. 
 
  
Sarah N. Sipe  April 2015 
Honors Thesis 
 
 
20	  
	  
8.    References 
[1]   Alzheimer’s Association Homepage.  http://www.alz.org/ 
[2]   Rafii, M.; Aisen, P.  Advances in Alzheimer’s Disease Drug Development, BMC Medicine 
2015, 13:62. 
[3]   Kepp, K. P. Bioinorganic Chemistry of Alzheimer’s Disease. Chem. Rev. 2012, 112, 5193-
5239.  
[4]   Sacco, C.; Skowronsky, R.; Gade, S.; Kenny, J.; Spuches, A. Calorimetric invesitagtion of 
copper (II) binding to Aβ peptides: thermodynamics of coordination plasticity. J. Biol. 
Inorg. Chem. 2012, 17:1. 
[5]   Olofsson, A.; Linghagen-Persson, M.; Vestling, M.; Sauer-Eriksson, E.; Öhman, A.  
Quenched hydrogen/deuterium exchange NMR characterization of amyloid-β peptide 
aggregates formed in the presence of Cu2+ or Zn2+. FEBS Journal 2009, 276, 4051-4060. 
[6]   Rogaeva, E. The solved and unsolved mysteries of the genetics of early-onset Alzheimer’s 
disease. NeuroMolecular Medicine 2002, 2, 1-10.   
[7]   Syme, C.; Nadal, R.; Rigby, S.; Viles, J. Copper binding to the Amyloid-β (Aβ) Peptide 
Associated with Alzheimer’s Disease. J. Biol. Chem. 2004, 279, 18169-18177. 
[8]   Hong, L.; Carducci, T.; Bush, W.; Dudzik, C.; Millhauser, G.; Simon, J. Quantification of 
the Binding Properties of Cu2+ to the Amyloid-Beta Peptide: Coordination Spheres for 
Human and Rat Peptides and Implication of Cu2+-Induced Aggregation. J. Phys. Chem. 
2010, 114, 11261-11271. 
[9]   Liu, R.; McAllister, C.; Lyubchenko, Y.; Sierks, M. Residues 17-20 and 30-35 of Beta-
Amyloid Play Critical Roles in Aggregation. J. Neurosci. 2004, 75, 162-171. 
[10] Gade, S. Cu2+
 
Binding to Aβ peptides: Detailed Heat Capacity Studies Provide Structural 
Insight into Complex Formation. Masters Thesis, East Carolina University, Greenville, NC, 
2013. 
[11] Onderka, B. The Heat Capacity of Bismuth Silicates. Thermochimica Acta 2015, 601, 68-
74. 
[12] Schönbeck, C.; Holm, R.; Westh, P.; Peters, G. Extending the Hydrophobic Cavity of β-
cyclodextrin results in more negative heat capacity changes but reduced binding affinities. J. 
Incl. Phenom. Macrocycl. Chem. 2013, 78, 351-361. 
[13] Lakowicz, J. Principles of Fluorescence Spectroscopy, 3rd Ed.; Springer Science + Business 
Media, LLC: New York, 2006. 
	  
